UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON

Federal contract awards won by UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON (UEI MSPWVMXXMN76), 2017–2026 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

28
awards
8
expiring in 12 months
2
agencies

Teaming snapshot

teams under 7 primes.

From subcontract reports primes file with USAspending/FSRS.

How their work has changed

Their work has changed a lot over the last two years.

Biggest change: Research and Development in Biotechnology (541711) went from 62% of their contracts to 25%.

Industry (NAICS)2 years beforeLast 2 years
Research and Development in Biotechnology (541711)62%25%
Research and Development in Biotechnology (except Nanobiotechnology) (541714)8%30%
Analytical Laboratory Instrument Manufacturing (334516)0%10%
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)15%25%
Colleges, Universities, and Professional Schools (611310)15%10%

Share of their contracts in each industry code: the last 24 months compared with the 24 months before, as of Nov 19, 2026. Shown only for companies with at least 5 contracts in each period.

Where their reported work happens

StateReported subawards
TX4

Place of performance on subcontract reports filed with USAspending/FSRS.

Category award history

25 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: MUCOMMUNE LLC took Department of Health and Human Services 541715 work from UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON (Sep 30, 2025).

Agencies buying from UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON

Awards

EVALUATION OF THERAPEUTICS AND VACCINES IN MOUSE MODELS OF DENGUE VIRUS.
Department of Health and Human Services · $844,795 · Sep 15, 2026
MOUSE AND GUINEA PIG MODELS FOR CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUSES
Department of Health and Human Services · $2,343,311 · Sep 15, 2025
TASK A02 - UNIVERSITY OF TEXAS MEDICAL BRANCH (UTMB)
Department of Health and Human Services · $2,603,774 · Sep 20, 2024
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREAS A, B, C, AND D
Department of Health and Human Services · No current value reported · Jul 15, 2024
MODEL DEVELOPMENT AND MEDICAL COUNTER MEASURES (MCMS) FOR BSL-4 AGENTS IN NHPS.
Department of Health and Human Services · $3,270,971 · Jun 25, 2024
PRECLINICAL MODELS OF INFECTIOUS DISEASES
Department of Health and Human Services · $1,199,853 · Apr 15, 2024
FY23 BAA - TOPIC 24 - UTMB
Department of Health and Human Services · $390,168 · Sep 1, 2023
SARS COV-2 ANIMAL MODELS FOR RISK ASSESSMENT OF VIRAL PATHOGENESIS
Department of Health and Human Services · $1,599,820 · Aug 5, 2022
PRECLINICAL MODELS OF INFECTIOUS DISEASES
Department of Health and Human Services · $472,205 · Feb 10, 2022
ISSUE TASK ORDER A63
Department of Health and Human Services · $5,848,314 · Nov 2, 2021
TO ISSUE PCMID B13 TASK ORDER AWARD
Department of Health and Human Services · $954,114 · Sep 24, 2021
TESTING OF STANDARD DRUGS FOR MYCOBACTERIUM TUBERCULOSIS (MTB) IN ANIMAL MODELS FOR MTB
Department of Health and Human Services · $347,684 · Aug 15, 2021
FY 21 BAA TOPIC 8 - UTMB
Department of Health and Human Services · $712,518 · Jun 1, 2021
MEDICAL DATA TRANSLATION TO ENGLISH FOR COVID19 SEAFOOD WORKERS STUDY
Department of Health and Human Services · $265,000 · May 18, 2021
PCMID IDIQ
Department of Health and Human Services · $1,129,744 · Jul 17, 2020
TO ISSUE TASK C06 TASK ORDER AWARD IN THE BASE AMOUNT OF $388,097.
Department of Health and Human Services · $1,179,662 · Aug 16, 2019